Neuroblastoma Global Market Report 2025

Neuroblastoma Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuroblastoma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for neuroblastoma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neuroblastoma market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product Types: Tablets; Vaccines; Other Product Types

2) By Treatment Type: Chemotherapy; Immunotherapy; Other Treatment Types

3) By Distribution Channel: Online; Offline

4) By End-User: Hospitals; Clinics

Subsegments:

1) By Tablets: Oral Chemotherapy Tablets; Targeted Therapy Tablets

2) By Vaccines: Immunotherapy Vaccines; Therapeutic Vaccines

3) By Other Product Types: Injectable Drugs; Monoclonal Antibodies; Cell Therapy Products

Companies Mentioned:Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Eli Lilly and Company; Sartorius AG; Recordati S.p.A

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Neuroblastoma Market Characteristics
3. Neuroblastoma Market Trends And Strategies
4. Neuroblastoma Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Neuroblastoma Growth Analysis And Strategic Analysis Framework
5.1. Global Neuroblastoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Neuroblastoma Market Growth Rate Analysis
5.4. Global Neuroblastoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Neuroblastoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Neuroblastoma Total Addressable Market (TAM)
6. Neuroblastoma Market Segmentation
6.1. Global Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Vaccines
Other Product Types
6.2. Global Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemotherapy
Immunotherapy
Other Treatment Types
6.3. Global Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online
Offline
6.4. Global Neuroblastoma Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
6.5. Global Neuroblastoma Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Chemotherapy Tablets
Targeted Therapy Tablets
6.6. Global Neuroblastoma Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunotherapy Vaccines
Therapeutic Vaccines
6.7. Global Neuroblastoma Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Drugs
Monoclonal Antibodies
Cell Therapy Products
7. Neuroblastoma Market Regional And Country Analysis
7.1. Global Neuroblastoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Neuroblastoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Neuroblastoma Market
8.1. Asia-Pacific Neuroblastoma Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Neuroblastoma Market
9.1. China Neuroblastoma Market Overview
9.2. China Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Neuroblastoma Market
10.1. India Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Neuroblastoma Market
11.1. Japan Neuroblastoma Market Overview
11.2. Japan Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Neuroblastoma Market
12.1. Australia Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Neuroblastoma Market
13.1. Indonesia Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Neuroblastoma Market
14.1. South Korea Neuroblastoma Market Overview
14.2. South Korea Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Neuroblastoma Market
15.1. Western Europe Neuroblastoma Market Overview
15.2. Western Europe Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Neuroblastoma Market
16.1. UK Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Neuroblastoma Market
17.1. Germany Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Neuroblastoma Market
18.1. France Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Neuroblastoma Market
19.1. Italy Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Neuroblastoma Market
20.1. Spain Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Neuroblastoma Market
21.1. Eastern Europe Neuroblastoma Market Overview
21.2. Eastern Europe Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Neuroblastoma Market
22.1. Russia Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Neuroblastoma Market
23.1. North America Neuroblastoma Market Overview
23.2. North America Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Neuroblastoma Market
24.1. USA Neuroblastoma Market Overview
24.2. USA Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Neuroblastoma Market
25.1. Canada Neuroblastoma Market Overview
25.2. Canada Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Neuroblastoma Market
26.1. South America Neuroblastoma Market Overview
26.2. South America Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Neuroblastoma Market
27.1. Brazil Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Neuroblastoma Market
28.1. Middle East Neuroblastoma Market Overview
28.2. Middle East Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Neuroblastoma Market
29.1. Africa Neuroblastoma Market Overview
29.2. Africa Neuroblastoma Market, Segmentation By Product Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Neuroblastoma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Neuroblastoma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Neuroblastoma Market Competitive Landscape And Company Profiles
30.1. Neuroblastoma Market Competitive Landscape
30.2. Neuroblastoma Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Recordati S.p.A Overview, Products and Services, Strategy and Financial Analysis
31. Neuroblastoma Market Other Major And Innovative Companies
31.1. United Therapeutics Corporation
31.2. BeiGene Ltd.
31.3. MacroGenics Inc.
31.4. Y-mAbs Therapeutics Inc.
31.5. RedHill Biopharma Ltd.
31.6. Clarity Pharmaceuticals Ltd.
31.7. EUSA Pharma (UK) Ltd.
31.8. US WorldMeds LLC
31.9. Healio Inc.
31.10. Ascentage Pharma
31.11. Laboratorio Elea Phoenix S.A
31.12. Curis Inc.
31.13. PersonGen BioTherapeutics (Suzhou) Co. Ltd.
31.14. Essential Pharma S.A
31.15. Cellectar Biosciences Inc.
32. Global Neuroblastoma Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Neuroblastoma Market
34. Recent Developments In The Neuroblastoma Market
35. Neuroblastoma Market High Potential Countries, Segments and Strategies
35.1 Neuroblastoma Market In 2029 - Countries Offering Most New Opportunities
35.2 Neuroblastoma Market In 2029 - Segments Offering Most New Opportunities
35.3 Neuroblastoma Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings